Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Innate Pharma SA (FR:IPH)
PARIS:IPH
Holding FR:IPH?
Track your performance easily
See the Price Targets and Ratings of:
IPH Analyst Ratings
Hold
0 Buy
2 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
IPH Stock 12 Month Forecast
Average Price Target
€3.10
▲(116.51% Upside)
| Highest Price Target€3.10 | Average Price Target€3.10 | Lowest Price Target€3.10 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Kepler Capital
Reiterated
11/13/24
Goldman Sachs
Reiterated
09/12/24
IPH Analyst Recommendation Trends
Rating
Mar 24
Apr 24
May 24
Sep 24
Nov 24
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
5
4
5
7
7
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
5
4
5
7
7
Each month's total comprises the sum of three months' worth of ratings.
IPH Financial Forecast
IPH Stock Forecast FAQ
What is FR:IPH’s average 12-month price target, according to analysts?
Based on analyst ratings, Innate Pharma SA’s 12-month average price target is €3.10.
What is FR:IPH’s upside potential, based on the analysts’ average price target?
Innate Pharma SA has 116.51% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Innate Pharma SA a Buy, Sell or Hold?
Innate Pharma SA has a consensus rating of Hold, which is based on 0 buy ratings, 2 hold ratings and 0 sell ratings.
What is Innate Pharma SA’s share price target?
The average share price target for Innate Pharma SA is €3.10. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €3.10 ,and the lowest forecast is €3.10. The average share price target represents 116.51% Increase from the current price of €1.434.
The highest analyst share price target is €3.10 ,and the lowest forecast is €3.10. The average share price target represents 116.51% Increase from the current price of €1.434.
What do analysts say about Innate Pharma SA?
Innate Pharma SA’s analyst rating consensus is a Hold. This is based on the ratings of 2 Wall Streets Analysts.
How can I buy shares of Innate Pharma SA?
To buy shares of FR:IPH, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.